Watch for Toxicities From Immune Checkpoint Inhibitors
March 2024
You’ll get questions about adverse effects with immune checkpoint inhibitors (ICIs) as use increases.
Immune checkpoint inhibitors, such as pembrolizumab (Keytruda) or nivolumab (Opdivo), are a common type of cancer immunotherapy.
Cancer immunotherapy works by helping the patient’s immune system find and kill cancer cells. It’s different from chemotherapy, which directly targets dividing cells...malignant or healthy.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote